Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGORA: LRA vs LRA+GA in Rotator Cuff Repair
NCT05848375Recruiting
- Sponsor
- Elsan
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine and levobupivacaine in rotator cuff injury (2 arms), sponsored by Elsan. Primary endpoint: Systolic Blood Pressure at Day 0. Started Nov 2023; status: recruiting.
02
Drugs
ropivacainelevobupivacaine
03
Conditions
rotator cuff injury
Beyond the preview
Go deeper on NCT05848375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05848375.